Science
3 Things About CRISPR Therapeutics That Smart Investors Know – The Motley Fool
The company’s value isn’t reflected in typical performance metrics.
The gene-editing virtuoso CRISPR Therapeutics (NASDAQ:CRSP) is one of the most-watched stocks in biotech, and it’s no surprise why. CRISPR Therapeutics has a handful of different programs that could turn out to be low-risk cures for previously intractable…
Continue Reading
-
General5 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News15 hours agoDangerous driving charges, Maroochydore – Sunshine Coast
-
General24 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
General15 hours agoTasmanian woman drowns on day 5 of multi-day Franklin River rafting trip